Molecular framework of steroid/retinoid discrimination in 17β-hydroxysteroid dehydrogenase type 1 and photoreceptor-associated retinol dehydrogenase

Journal of Molecular Biology

Volumn 399, Issue 2, 2010, Pages 255-267

  Haller, Ferdinand ^a   Moman, Edelmiro ^b   Hartmann, Rolf W ^b,c   Adamski, Jerzy ^a,d   Mindnich, Rebekka ^e  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

17 hydroxysteroid dehydrogenase; Evolution; Mutagenesis; Photoreceptor associated retinol dehydrogenase; Protein multifunctionality

Indexed keywords

GLYCINE; METHIONINE; RETINOID; RETINOL; RETINOL DEHYDROGENASE; STEROID; TESTOSTERONE 17BETA DEHYDROGENASE;

AMINO ACID ANALYSIS; AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; CATALYSIS; CELL STRAIN HEK293; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBSTRATE; ENZYME SUBSTRATE COMPLEX; GENE EXPRESSION; GENE INSERTION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; MOLECULAR DOCKING; MOLECULAR MODEL; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; QUANTITATIVE STUDY; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WILD TYPE; ZEBRA FISH;

DANIO RERIO;

EID: 77953083038     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.04.002     Document Type: Article

References (57)

1. Moore T. Vitamin A 1957, Elsevier Science Publishing Co., New York.
2. Wolf G. Multiple functions of vitamin A. Physiol. Rev. 1984, 64:873-937.
3. Morriss-Kay G.M., Ward S.J. Retinoids and mammalian development. Int. Rev. Cytol. 1999, 188:73-131.
4. Prossnitz E.R., Maggiolini M. Non-genomic signaling by steroids. Mol. Cell. Endocrinol. 2009, 308:1-2.
5. Fox E.M., Andrade J., Shupnik M.A. Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways. Steroids 2009, 74:622-627.
6. Weiland N.G. Estradiol selectively regulates agonist binding sites on the N-methyl-D-aspartate receptor complex in the CA1 region of the hippocampus. Endocrinology 1992, 131:662-668.
7. Prossnitz E.R., Arterburn J.B., Smith H.O., Oprea T.I., Sklar L.A., Hathaway H.J. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu. Rev. Physiol. 2008, 70:165-190.
8. Liden M., Eriksson U. Understanding retinol metabolism: structure and function of retinol dehydrogenases. J. Biol. Chem. 2006, 281:13001-13004.
9. Moeller G., Adamski J. Integrated view on 17beta-hydroxysteroid dehydrogenases. Mol. Cell. Endocrinol. 2009, 301:7-19.
10. Lukacik P., Kavanagh K.L., Oppermann U. Structure and function of human 17beta-hydroxysteroid dehydrogenases. Mol. Cell. Endocrinol. 2006, 248:61-71.
11. Campo-Paysaa F., Marletaz F., Laudet V., Schubert M. Retinoic acid signaling in development: tissue-specific functions and evolutionary origins. Genesis 2008, 46:640-656.
12. Markov G.V., Tavares R., Dauphin-Villemant C., Demeneix B.A., Baker M.E., Laudet V. Independent elaboration of steroid hormone signaling pathways in metazoans. Proc. Natl Acad. Sci. USA 2009, 106:11913-11918.
13. Prehn C., Moller G., Adamski J. Recent advances in 17beta-hydroxysteroid dehydrogenases. J. Steroid Biochem. Mol. Biol. 2009, 114:72-77.
14. Persson B., Kallberg Y., Bray J.E., Bruford E., Dellaporta S.L., Favia A.D., et al. The SDR (short-chain dehydrogenase/reductase and related enzymes) nomenclature initiative. Chem. Biol. Interact. 2009, 178:94-98.
15. Poutanen M., Miettinen M., Vikho R. Differential estrogen substrate specificities for transiently expressed human placental 17beta-hydroxysteroid dehydrogenase and an endogenous enzyme expressed in cultured COS-m6 cells. Endocrinology 1993, 133:2639-2644.
16. Nokelainen P., Puranen T., Peltoketo H., Orava M., Vihko P., Vihko R. Molecular cloning of mouse 17 beta-hydroxysteroid dehydrogenase type 1 and characterization of enzyme activity. Eur. J. Biochem. 1996, 236:482-490.
17. Puranen T., Poutanen M., Ghosh D., Vihko R., Vihko P. Origin of substrate specificity of human and rat 17beta-hydroxysteroid dehydrogenase type 1, using chimeric enzymes and site-directed substitutions. Endocrinology 1997, 138:3532-3539.
18. Poirier D. Advances in development of inhibitors of 17beta-hydroxysteroid dehydrogenases. Anticancer Agents Med. Chem. 2009, 9:642-660.
19. Jansson A. 17beta-hydroxysteroid dehydrogenase enzymes and breast cancer. J. Steroid Biochem. Mol. Biol. 2009, 114:64-67.
20. Allan G.M., Vicker N., Lawrence H.R., Tutill H.J., Day J.M., Huchet Mi, et al. Novel inhibitors of 17beta-hydroxysteroid dehydrogenase type 1: templates for design. Bioorg. Med. Chem. 2008, 16:4438-4456.
21. Bey E., Marchais-Oberwinkler S., Negri M., Kruchten P., Oster A., Klein T., et al. New insights into the SAR and binding modes of bis(hydroxyphenyl)thiophenes and -benzenes: influence of additional substituents on 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) inhibitory activity and selectivity. J. Med. Chem. 2009, 52:6724-6743.
22. Marchais-Oberwinkler S., Kruchten P., Frotscher M., Ziegler E., Neugebauer A., Bhoga U., et al. Substituted 6-phenyl-2-naphthols. Potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1): design, synthesis, biological evaluation, and pharmacokinetics. J. Med. Chem. 2008, 51:4685-4698.
23. Moller G., Deluca D., Gege C., Rosinus A., Kowalik D., Peters O., et al. Structure-based design, synthesis and in vitro characterization of potent 17beta-hydroxysteroid dehydrogenase type 1 inhibitors based on 2-substitutions of estrone and D-homo-estrone. Bioorg. Med. Chem. Lett. 2009, 19:6740-6744.
24. Rattner A., Smallwood P.M., Nathans J. Identification and characterization of all-trans-retinol dehydrogenase from photoreceptor outer segments, the visual cycle enzyme that reduces all-trans-retinal to all-trans-retinol. J. Biol. Chem. 2000, 275:11034-11043.
25. Rando R.R. The biochemistry of the visual cycle. Chem. Rev. 2001, 101:1881-1896.
26. Saari J.C., Garwin G.G., Van Hooser J.P., Palczewski K. Reduction of all-trans-retinal limits regeneration of visual pigment in mice. Vision Res. 1998, 38:1325-1333.
27. Maeda A., Maeda T., Sun W., Zhang H., Baehr W., Palczewski K. Redundant and unique roles of retinol dehydrogenases in the mouse retina. Proc. Natl Acad. Sci. USA 2007, 104:19565-19570.
28. Maeda A., Maeda T., Golczak M., Palczewski K. Retinopathy in mice induced by disrupted all-trans-retinal clearance. J. Biol. Chem. 2008, 283:26684-26693.
29. Mindnich R., Deluca D., Adamski J. Identification and characterization of 17 beta-hydroxysteroid dehydrogenases in the zebrafish, Danio rerio. Mol. Cell. Endocrinol. 2004, 215:19-30.
30. Breton R., Housset D., Mazza C., Fontecilla-Camps J.C. The structure of a complex of human 17beta-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors. Structure 1996, 4:905-915.
31. Lin S.X., Zhu D.W., Azzi A., Campbell R.L., Breton R., Labrie F., et al. Studies on the three-dimensional structure of estrogenic 17beta-hydroxysteroid dehydrogenase. J. Endocrinol. 1996, 150:S13-S20.
32. Tajkhorshid E., Baudry J., Schulten K., Suhai S. Molecular dynamics study of the nature and origin of retinal's twisted structure in bacteriorhodopsin. Biophys. J. 2000, 78:683-693.
33. Jensen R.A. Enzyme recruitment in evolution of new function. Annu. Rev. Microbiol. 1976, 30:409-425.
34. O'Brien P.J., Herschlag D. Catalytic promiscuity and the evolution of new enzymatic activities. Chem. Biol. 1999, 6:R91-R105.
35. Aharoni A., Gaidukov L., Khersonsky O., Mc Q.G.S., Roodveldt C., Tawfik D.S. The 'evolvability' of promiscuous protein functions. Nat. Genet. 2005, 37:73-76.
36. Khersonsky O., Roodveldt C., Tawfik D.S. Enzyme promiscuity: evolutionary and mechanistic aspects. Curr. Opin. Chem. Biol. 2006, 10:498-508.
37. Jez J.M., Penning T.M. Engineering steroid 5beta-reductase activity into rat liver 3alpha-hydroxysteroid dehydrogenase. Biochemistry 1998, 37:9695-9703.
38. Tarrant A.M., Reitzel A.M., Blomquist C.H., Haller F., Tokarz J., Adamski J. Steroid metabolism in cnidarians: insights from Nematostella vectensis. Mol. Cell. Endocrinol. 2009, 301:27-36.
39. Baker M.E. Evolution of 17beta-hydroxysteroid dehydrogenases and their role in androgen, estrogen and retinoid action. Mol. Cell. Endocrinol. 2001, 171:211-215.
40. Maeda A., Maeda T., Imanishi Y., Kuksa V., Alekseev A., Bronson J.D., et al. Role of photoreceptor-specific retinol dehydrogenase in the retinoid cycle in vivo. J. Biol. Chem. 2005, 280:18822-18832.
41. Ito K., Utsunomiya H., Yaegashi N., Sasano H. Biological roles of estrogen and progesterone in human endometrial carcinoma-new developments in potential endocrine therapy for endometrial cancer. Endocr. J. 2007, 54:667-679.
42. Ginestier C., Wicinski J., Cervera N., Monville F., Finetti P., Bertucci F., et al. Retinoid signaling regulates breast cancer stem cell differentiation. Cell Cycle 2009, 8:3297-3302.
43. Suzuki T., Moriya T., Sugawara A., Ariga N., Takabayashi H., Sasano H. Retinoid receptors in human breast carcinoma: possible modulators of in situ estrogen metabolism. Breast Cancer Res. Treat. 2001, 65:31-40.
44. Husen B., Huhtinen K., Poutanen M., Kangas L., Messinger J., Thole H. Evaluation of inhibitors for 17beta-hydroxysteroid dehydrogenase type 1 in vivo in immunodeficient mice inoculated with MCF-7 cells stably expressing the recombinant human enzyme. Mol. Cell. Endocrinol. 2006, 248:109-113.
45. Shen Z., Saloniemi T., Ronnblad A., Jarvensivu P., Pakarinen P., Poutanen M. Sex steroid-dependent and -independent action of hydroxysteroid (17beta) dehydrogenase 2: evidence from transgenic female mice. Endocrinology 2009, 150:4941-4949.
46. Saloniemi T., Welsh M., Lamminen T., Saunders P., Makela S., Streng T., Poutanen M. Human HSD17B1 expression masculinizes transgenic female mice. Mol. Cell. Endocrinol. 2009, 301:163-168.
47. Katoh K., Toh H. Recent developments in the MAFFT multiple sequence alignment program. Brief. Bioinform. 2008, 9:286-298.
48. Sali A., Blundell T.L. Comparative protein modelling by satisfaction of spatial constraints. J. Mol. Biol. 1993, 234:779-815.
49. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993, 26:283-291.
50. Trott O., Olson A.J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010, 31:455-461.
51. Morris G.M., Huey R., Lindstrom W., Sanner M.F., Belew R.K., Goodsell D.S., Olson A.J. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 2009, 30:2785-2791.
52. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
53. Mindnich R., Haller F., Halbach F., Moeller G., Hrabe de Angelis M., Adamski J. Androgen metabolism via 17beta-hydroxysteroid dehydrogenase type 3 in mammalian and non-mammalian vertebrates: comparison of the human and the zebrafish enzyme. J. Mol. Endocrinol. 2005, 35:305-316.
54. Chetyrkin S.V., Hu J., Gough W.H., Dumaual N., Kedishvili N.Y. Further characterization of human microsomal 3alpha-hydroxysteroid dehydrogenase. Arch. Biochem. Biophys. 2001, 386:1-10.
55. Kumar S., Nei M., Dudley J., Tamura K. MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief. Bioinform. 2008, 9:299-306.
56. Kavanagh K.L., Jornvall H., Persson B., Oppermann U. Medium- and short-chain dehydrogenase/reductase gene and protein families: the SDR superfamily: functional and structural diversity within a family of metabolic and regulatory enzymes. Cell. Mol. Life Sci. 2008, 65:3895-3906.
57. Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 2004, 25:1605-1612.